“…Generally, experimental studies on caffeine effects in AD demonstrated some beneficial influence on cognition. Its neuroprotective, antioxidant, anti-inflammatory and antiapoptotic activities in the neuronal tissues, led to alleviation of cognitive impairment [104,119,122,123,128,[131][132][133]136,[141][142][143]155,156,158,160,161,[164][165][166]. Many studies pointed out on favorable effects of caffeine on the hallmarks of the disease: Aβ or hyperphosphorylated tau protein [104,117,129,131,134,156,161,162,[164][165][166].…”